Literature DB >> 21051678

The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease.

Matthew Menza1, Roseanne Defronzo Dobkin, Humberto Marin, Margery H Mark, Michael Gara, Karina Bienfait, Allison Dicke, Alex Kusnekov.   

Abstract

BACKGROUND: Parkinson's disease (PD) affects patients' lives with more than just physical impairment. Many of the non-motor aspects of PD, such as cognitive impairment, depression, and sleep disturbances, are common and are associated with a variety of poor outcomes. However, at present, the pathophysiology and clinical management of these symptoms are poorly understood.
OBJECTIVE: The authors sought to determine the associations between various illness-associated cytokines, cortisol, and the non-motor symptoms of PD.
METHOD: The authors examined a panel of cytokines (IL-1β, IL-6, IL-10, TNF-α) and cortisol in a cohort of 52 PD patients with depression.
RESULTS: There were a number of significant correlations between the non-motor symptoms and TNF-α. Specifically, the authors found that TNF-α (but not IL-1β, IL-6, IL-10, or cortisol) was significantly correlated with measures of cognition, depression, and disability. In regression analyses accounting for all variables, TNF-α was consistently significant in explaining variance in cognition, depression, sleep, and disability.
CONCLUSION: These data are consistent with a growing body of literature that implicates inflammatory cytokines in neural and behavioral processes and further suggests that TNF-α may be involved in the production and/or maintenance of non-motor symptoms in PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21051678      PMCID: PMC2987579          DOI: 10.1176/appi.psy.51.6.474

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  32 in total

1.  Health related quality of life in Parkinson's disease: a prospective longitudinal study.

Authors:  K H Karlsen; E Tandberg; D Arsland; J P Larsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-11       Impact factor: 10.154

Review 2.  Cytokines and cognition--the case for a head-to-toe inflammatory paradigm.

Authors:  Craig J Wilson; Caleb E Finch; Harvey J Cohen
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

Review 3.  Depression and Parkinson's disease: a review.

Authors:  J L Cummings
Journal:  Am J Psychiatry       Date:  1992-04       Impact factor: 18.112

Review 4.  Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: a systematic review.

Authors:  Christine A Szekely; Jennifer E Thorne; Peter P Zandi; Mats Ek; Erick Messias; John C S Breitner; Steven N Goodman
Journal:  Neuroepidemiology       Date:  2004 Jul-Aug       Impact factor: 3.282

Review 5.  Cytokines and the central nervous system.

Authors:  J Szelényi
Journal:  Brain Res Bull       Date:  2001-03-01       Impact factor: 4.077

6.  Short form 36 (SF36) health survey questionnaire: normative data for adults of working age.

Authors:  C Jenkinson; A Coulter; L Wright
Journal:  BMJ       Date:  1993-05-29

7.  Psychometric evaluation of the Pittsburgh Sleep Quality Index.

Authors:  J S Carpenter; M A Andrykowski
Journal:  J Psychosom Res       Date:  1998-07       Impact factor: 3.006

8.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

Authors:  G Boka; P Anglade; D Wallach; F Javoy-Agid; Y Agid; E C Hirsch
Journal:  Neurosci Lett       Date:  1994-05-19       Impact factor: 3.046

9.  Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study.

Authors:  Dag Aarsland; Kjeld Andersen; Jan P Larsen; Anette Lolk; Per Kragh-Sørensen
Journal:  Arch Neurol       Date:  2003-03

10.  The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.

Authors:  Matthew Menza; Roseanne DeFronzo Dobkin; Humberto Marin; Margery H Mark; Michael Gara; Steven Buyske; Karina Bienfait; Allison Dicke
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

View more
  55 in total

1.  A Prospective Evaluation of Systemic Biomarkers and Cognitive Function Associated with Carotid Revascularization.

Authors:  Mary C Zuniga; Thuy B Tran; Brittanie D Baughman; Gayatri Raghuraman; Elizabeth Hitchner; Allyson Rosen; Wei Zhou
Journal:  Ann Surg       Date:  2016-10       Impact factor: 12.969

Review 2.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 3.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

4.  TRANSLATION OF BRAIN ACTIVITY INTO SLEEP.

Authors:  James M Krueger
Journal:  Hirosaki Igaku       Date:  2012

Review 5.  Depression in Parkinson disease--epidemiology, mechanisms and management.

Authors:  Dag Aarsland; Sven Påhlhagen; Clive G Ballard; Uwe Ehrt; Per Svenningsson
Journal:  Nat Rev Neurol       Date:  2011-12-26       Impact factor: 42.937

6.  Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.

Authors:  Hossein Sanjari Moghaddam; Zahra Valitabar; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Farzaneh Ghazi Sherbaf; Mohammad Hadi Aarabi
Journal:  Neuromolecular Med       Date:  2018-07-06       Impact factor: 3.843

Review 7.  The therapeutic potential of interleukin-10 in neuroimmune diseases.

Authors:  A J Kwilasz; P M Grace; P Serbedzija; S F Maier; L R Watkins
Journal:  Neuropharmacology       Date:  2014-11-04       Impact factor: 5.250

8.  Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.

Authors:  Edward Tobinick
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

Review 9.  Animal models of the non-motor features of Parkinson's disease.

Authors:  Kimberly McDowell; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2012-01-03       Impact factor: 5.996

Review 10.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.